Omega Diagnostics Group PLC Director/PDMR Shareholding (4012J)
August 15 2023 - 8:45AM
UK Regulatory
TIDMODX
RNS Number : 4012J
Omega Diagnostics Group PLC
15 August 2023
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Director/PDMR Shareholding
Omega (AIM: ODX), the specialist medical diagnostics company
focused on industry-leading Health and Nutrition products,
announces that on 14 August 2023 it received notification that Jag
Grewal, Chief Executive Officer, had purchased 296,009 ordinary
shares of 4 pence each in the Company ("Ordinary Shares"), at a
price of 2.70 pence each.
A summary of Mr Grewal's resultant holdings is below:
Director Board Position Existing number of Ordinary Shares Total beneficial holding of Ordinary
Ordinary Shares Purchased Shares following this acquisition
Number of Ordinary Approximate % of
Shares Company's issued
share capital
--------------------
Jag Grewal CEO 2,164,830 296,009 2,460,839 1.03%
---------------- -------------------- -------------------- -------------------- --------------------
Contacts:
Omega Diagnostics Group PLC www.omegadx.com
Jag Grewal, Chief Executive Officer via Walbrook PR
Chris Lea, Chief Financial Officer
finnCap Ltd Tel: 020 7220 0500
Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)
Nigel Birks / Harriet Ward (ECM)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus / Lianne Applegarth Mob: 07980 541 893 / 07584 391 303
Sam Allen Mob: 07502 558 258
About Omega Diagnostics Group PLC
Omega manufactures and distributes high quality in-vitro
diagnostic products for use in hospitals, clinics, laboratories and
healthcare practitioners in over 85 countries and is now focused on
the health and nutrition sector.
www.omegadx.com
Notification of transactions of persons discharging managerial
responsibilities and persons closely associated with them
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Jag Grewal
------------------------- -------------------------------------
Reason for the notification
2
----------------------------------------------------------------
a) Position/status Chief Executive Officer
------------------------- -------------------------------------
b) Initial notification Initial Notification
/Amendment
------------------------- -------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
----------------------------------------------------------------
a) Name Omega Diagnostics Group PLC
------------------------- -------------------------------------
b) LEI 2138007U9P4BTZTYIR92
------------------------- -------------------------------------
Details of the transaction(s): section to be repeated for
4 (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
----------------------------------------------------------------
a) Description Ordinary Shares of 4 pence each
of the financial
instrument,
type of instrument
Identification ISIN: GB00B1VCP282
code
------------------------- -------------------------------------
b) Nature of Ordinary Shares purchased
the transaction
------------------------- -------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
2.70 pence 296,009
------------ ----------
------------------------- -------------------------------------
d) Aggregated See above
information
-Aggregated
volume
- Price
------------------------- -------------------------------------
e) Date of the 14.08.2023
transaction
------------------------- -------------------------------------
f) Place of the London Stock Exchange
transaction
------------------------- -------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBDGDIXSBDGXU
(END) Dow Jones Newswires
August 15, 2023 08:45 ET (12:45 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Jul 2023 to Jul 2024